UCB
This role involves conducting innovative research within a global biopharmaceutical environment to develop advanced human in vitro neural models for neurological disease and pain biology. The position focuses on generating phenotypic and mechanistic insights to support target or therapeutic discovery in a dynamic drug discovery setting. The scientist will collaborate with multidisciplinary teams to connect human disease biology with advanced cellular models for translational knowledge.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
R-251294 Principal Scientist – Chemical Biology & Proximity-Based Therapeutics
Amgen
Director of In Vitro Pharmacology
Eli Lilly and Company
Principal Scientist, Advanced Ocular In Vitro Models
Sanofi
Senior Scientist
MSD
Senior Scientist
Merck & Co., Inc.
Advisor / Senior Advisor, CNS/PNS NAMs – Investigative Toxicology
Eli Lilly and Company